Discovery of a novel soluble Neuropilin-2 isoform with antiangiogenic and antitumorigenic activity

Mayr T, Dix PL, Hasheminasab SM, Hampel C, Sylvester M, Schneberger N, Foerster S, Hagelueken G, Dutta S, Kristiansen G, Schneider-Stock R, Datta K, Muders MH (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Cancer Research American Association for Cancer Research

Publisher: AMER ASSOC CANCER RESEARCH

City/Town: PHILADELPHIA

Conference Proceedings Title: CANCER RESEARCH

Event location: New Orleans, LA

DOI: 10.1158/1538-7445.AM2022-831

Authors with CRIS profile

Chuanpit Hampel Institute of Pathology Regine Schneider-Stock Professur für Experimentelle Tumorpathologie

Involved external institutions

Rheinische Friedrich-Wilhelms-Universität Bonn DE Germany (DE) Universitätsklinikum Bonn DE Germany (DE) University of Nebraska Medical Center (UNMC) US United States (USA) (US) Charité - Universitätsmedizin Berlin DE Germany (DE)

How to cite

APA:

Mayr, T., Dix, P.L., Hasheminasab, S.-M., Hampel, C., Sylvester, M., Schneberger, N.,... Muders, M.H. (2022). Discovery of a novel soluble Neuropilin-2 isoform with antiangiogenic and antitumorigenic activity. In CANCER RESEARCH. New Orleans, LA: PHILADELPHIA: AMER ASSOC CANCER RESEARCH.

MLA:

Mayr, Thomas, et al. "Discovery of a novel soluble Neuropilin-2 isoform with antiangiogenic and antitumorigenic activity." Proceedings of the Annual Meeting of the American-Association-for-Cancer-Research (AACR), New Orleans, LA PHILADELPHIA: AMER ASSOC CANCER RESEARCH, 2022.

BibTeX: Download